Eurex US has filed an amended antitrust suit against Chicago
Board of Trade (CBoT) and Chicago Mercantile Exchange (CME)
alleging illegal price cutting, which Eurex claimed has been
responsible for the unimpressive performance of its US Treasury
The main allegation of the revised suit, filed on 25 March,
is against CBoT, for slashing or waiving its exchange fees for
US interest rate futures to compete with Eurex US.
The suit claims: "as a result, one year after its launch,
[Eurex US] has failed to capture a more than trivial portion of
the market. Defendants' illegal conduct has deprived consumers
of meaningful competition among venues for trading US Treasury
futures and options."
This article is available exclusively to subscribers
Please log in to continue reading.
Not yet a subscriber?
Click here to take a free trial.
Already have an account? |
Please fill in your details below and a customer service representative will contact you.